COMBINATIONS OF EPIDERMAL GROWTH FACTOR RECEPTOR TARGETING ANTIBODIES FOR TREATING CANCER

• 收藏
• 分享

专利权人:

Yeda Research and Development Co. Ltd.

发明人:

Yosef YARDEN,Michael SELA,Ruth MARON,FERRARO Daniela Aleida

申请号：

US15935010

公开号：

US20180208674A1

申请日:

2018.03.25

申请国别(地区):

US

年份:

2018

代理人:

摘要：

A method of treating triple negative breast cancer in a subject comprising administering to the subject a therapeutically effective amount of a combination of at least two anti epidermal growth factor receptor (EGF-R) antibodies exhibiting binding to different epitopes on the EGF-R, thereby treating triple negative breast cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/